CervoMed Inc (CRVO)
24.08
-0.28
(-1.15%)
USD |
NASDAQ |
May 17, 12:15
CervoMed Total Assets (Quarterly): 9.972M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.972M |
September 30, 2023 | 12.04M |
June 30, 2023 | 15.69M |
March 31, 2023 | 18.40M |
December 31, 2022 | 4.158M |
September 30, 2022 | 26.32M |
June 30, 2022 | 29.18M |
March 31, 2022 | 33.57M |
December 31, 2021 | 37.84M |
September 30, 2021 | 40.88M |
June 30, 2021 | 52.71M |
March 31, 2021 | 56.21M |
December 31, 2020 | 27.73M |
September 30, 2020 | 31.92M |
June 30, 2020 | 35.99M |
March 31, 2020 | 21.06M |
December 31, 2019 | 24.11M |
September 30, 2019 | 16.20M |
June 30, 2019 | 18.93M |
March 31, 2019 | 15.99M |
December 31, 2018 | 18.20M |
September 30, 2018 | 23.59M |
June 30, 2018 | 29.94M |
March 31, 2018 | 33.37M |
December 31, 2017 | 26.15M |
Date | Value |
---|---|
September 30, 2017 | 28.33M |
June 30, 2017 | 33.91M |
March 31, 2017 | 36.34M |
December 31, 2016 | 17.48M |
September 30, 2016 | 19.05M |
June 30, 2016 | 19.92M |
March 31, 2016 | 22.91M |
December 31, 2015 | 2.277M |
September 30, 2015 | 23.38M |
June 30, 2015 | 36.65M |
March 31, 2015 | 39.62M |
December 31, 2014 | 42.78M |
September 30, 2014 | 50.55M |
June 30, 2014 | 54.53M |
March 31, 2014 | 26.45M |
December 31, 2013 | 18.34M |
September 30, 2013 | 3.234M |
June 30, 2013 | 0.1975M |
March 31, 2013 | 2.188M |
December 31, 2012 | 2.446M |
September 30, 2012 | 3.944M |
June 30, 2012 | 3.709M |
March 31, 2012 | 3.575M |
December 31, 2011 | 3.674M |
September 30, 2011 | 9.081M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.158M
Minimum
Dec 2022
56.21M
Maximum
Mar 2021
27.00M
Average
26.32M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
GlucoTrack Inc | 4.905M |
AIM ImmunoTech Inc | 19.38M |
Perspective Therapeutics Inc | 97.89M |
Protalix BioTherapeutics Inc | 89.82M |
Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.596M |
Shareholders Equity (Quarterly) | 7.377M |